^
Association details:
| Biomarker: | TERT mutation + ERBB4 mutation |
|---|---|
| Cancer: | Colon Cancer |
| Drug Class: | Immunotherapy |
| Direction: | Sensitive |
Evidence:
Source:
Title:
Multi-OMICs data analysis identifies molecular features correlating with tumor immunity in colon cancer
Excerpt:
Two gene mutations (TERT and ERBB4) correlated with antitumor cytolytic activity found also correlated with improved survival in immunotherapy-treated colon cancers.
DOI:
10.3233/CBM-210222
